Cargando…
Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date
Inhaled levodopa is a newly emerging therapeutic option in the treatment of “off ” symptoms associated with Parkinson’s disease (PD). Its mode of delivery offers more rapid absorption of levodopa and shorter onset of clinical benefit compared to oral formulations, and has been shown to be feasible f...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220433/ https://www.ncbi.nlm.nih.gov/pubmed/30464480 http://dx.doi.org/10.2147/NDT.S147633 |